drugset / Trial / NCT00319956
Trial II of Lung Protection With Azithromycin in the Preterm Infant
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The hypothesis of this study is that administration of azithromycin to ventilated premature infants will decrease the incidence and severity of BPD. The purpose of this study is to determine if Azithromycin treatment is beneficial for prevention of bronchopulmonary dysplasia in preterm infants.
Timeline
- Start
- 2004-09
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 5 mg/kg | Intravenous |